Lexaria Bioscience Corp.: Lexaria Examining Potential Therap

KELOWNA, BC / ACCESSWIRE / November 10, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that study program

Related Keywords

Canada , Kelowna , British Columbia , George Jurcic , Exchange Commission , Lexaria Bioscience Corp , Lexaria Bioscience Corp View , Company Or Lexaria , World Health Organization , Drug Administration , Nasdaq , Lexaria Bioscience , Lexaria , Ioscience , Orp , Examining , Potential , Herapeutic , Dehydratech , Dementia ,